Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to -$2.6 million.

  • AtriCure's Cash from Investing Activities fell 15931.24% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.6 million, marking a year-over-year decrease of 16321.87%. This contributed to the annual value of $30.2 million for FY2024, which is 3858.0% up from last year.
  • Per AtriCure's latest filing, its Cash from Investing Activities stood at -$2.6 million for Q3 2025, which was down 15931.24% from -$7.7 million recorded in Q2 2025.
  • AtriCure's 5-year Cash from Investing Activities high stood at $63.6 million for Q1 2021, and its period low was -$25.1 million during Q3 2021.
  • Its 5-year average for Cash from Investing Activities is $5.7 million, with a median of $1.1 million in 2021.
  • In the last 5 years, AtriCure's Cash from Investing Activities soared by 55013.93% in 2022 and then crashed by 42738.69% in 2024.
  • Over the past 5 years, AtriCure's Cash from Investing Activities (Quarter) stood at $1.1 million in 2021, then skyrocketed by 550.14% to $7.0 million in 2022, then tumbled by 139.79% to -$2.8 million in 2023, then crashed by 427.39% to -$14.7 million in 2024, then soared by 82.27% to -$2.6 million in 2025.
  • Its Cash from Investing Activities was -$2.6 million in Q3 2025, compared to -$7.7 million in Q2 2025 and -$1.7 million in Q1 2025.